NHS launches free high-street cholesterol tests to prevent heart attacks and strokes

The NHS in England is launching a new kind of health checkpoint: a seven-minute finger-prick blood test for cholesterol that anyone between 40 and 84 can walk into a pharmacy and request, free of charge. It is the first time the health service has offered this screening on the high street, and it represents a deliberate shift in how preventive care reaches people — moving it out of GP surgeries and into the places where people already shop.

The tests work simply. A pharmacist uses a small lancet to prick a fingertip, draws a tiny amount of blood, and analyzes it on the spot. Within minutes, the patient has their cholesterol reading and a blood pressure check. If the results suggest risk, the pharmacist can offer lifestyle advice or recommend medication like statins. Results are emailed to the patient, creating a record they can take to their GP if needed. The eligibility is broad: anyone aged 40 to 84 who has not had a blood test in the past year and is not pregnant can participate.

The scheme emerged from a successful pilot run by Barts Health NHS trust in north London, conducted in partnership with UCLPartners and the cholesterol charity Heart UK. Between 2,493 patients tested in that trial, nearly one in five — 19 percent — were identified as at high risk of a heart attack or stroke within the next decade. That finding alone justified the approach: these were people who might not have sought a GP appointment, who might not have known their cholesterol levels, who were walking around unaware of their cardiovascular vulnerability. Of those identified, at least 88 began taking statins as a result of the screening.

The national rollout begins this autumn with approximately 100 NHS pharmacies across England. The ambition is larger: the NHS has set a target to reduce deaths from heart disease and stroke by a quarter within the next decade, and this initiative is positioned as a key tool toward that goal. David Webb, the chief pharmaceutical officer for England, framed it as early detection that prevents catastrophe. "By making it easier for people to get a quick and convenient cholesterol health check on their local high street, we can spot ticking timebombs earlier," he said, using language that captures both the clinical reality and the human stakes — people at risk who do not yet know it.

The scheme also carries a secondary purpose: reducing health inequalities. Dr Sotiris Antoniou, the clinical lead at Barts Health, noted that cardiovascular disease burden is not evenly distributed across England. Communities with the highest rates of heart disease and stroke stand to benefit most from preventive screening brought directly to them, rather than requiring a GP appointment that some may struggle to access or prioritize. Dr Rani Khatib, NHS England's national specialty adviser for cardiovascular disease prevention, emphasized that awareness of risk factors — knowing one's cholesterol and blood pressure numbers — is foundational to prevention. "This initiative will help people manage their risk factors earlier and reduce their risk of having heart attacks or strokes," he said.

Health minister Alison McGovern called it "exactly the type of innovation" the NHS needs. The framing from officials is consistent: this is care brought closer to home, detection made convenient, prevention made accessible. It is also a way to ease pressure on GP surgeries, which have faced mounting demand. By handling straightforward cholesterol screening at pharmacies, the system frees up GP time for more complex cases. The scheme was announced at the European Society of Cardiology's annual congress in Munich, positioned as the first of its kind globally — a distinction that signals both the novelty and the potential significance of the approach.